
Bay-y-1015 is an orally active quinoline-based 5-lipoxygenase ингибитор. Bay-y-1015 inhibits LTB4 and LTC4 synthesis. Bay-y-1015 can be used in the research of inflammatory diseases.
Bay-y-1015 is an orally active quinoline-based 5-lipoxygenase inhibitor. Bay-y-1015 inhibits LTB4 and LTC4 synthesis. Bay-y-1015 can be used in the research of inflammatory diseases.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.